Patients must not currently be receiving any other investigational agents
Subject is currently being treated with other investigational agents.
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving radiotherapy, biological therapy, or any other investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational agents
EXCLUSION CRITERIA FOR REGISTRATION: Currently receiving any other investigational agents or systemic cancer therapy
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Patients who are currently receiving or have previously received any other investigational agents within  weeks prior to entering the study
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Is currently receiving another investigational therapy
Currently receiving any other investigational agents
Currently receiving any other investigational agents or received any within the past  days
Patients who are currently receiving any other investigational agents.
Subjects who are currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving investigational agents that are intended as treatments of recurrent GBM.
Currently receiving any other investigational agents
Currently receiving any investigational agents
Currently receiving any other investigational agents
Currently receiving any investigational agents
Currently receiving radiotherapy, biological therapy, or any other investigational agents
Must not be currently receiving any investigational drugs
Currently receiving any other investigational agents
Currently receiving any other investigational agents that are intended as treatments of the relapsed tumor
Currently receiving any other investigational agents
Patients who are receiving concurrent chemotherapy, or who are currently receiving other investigational chemotherapeutic agents or concurrently receiving radiation
Currently receiving any other investigational agents, or received an investigational agent within  weeks of the first dose of nintedanib
Currently receiving any other investigational agents
Participants who are currently receiving any other investigational agents.
Currently receiving any other investigational agents, or exposure to any investigational drug or placebo within  weeks of study treatment
Currently receiving any other investigational agents
Currently receiving any other investigational agents.
Patients may not currently be receiving any other investigational agents for leukemia
Not currently receiving other investigational drugs
Patients currently receiving other investigational agents
Currently receiving any other investigational agents
Receiving any investigational agents currently or within  days prior to study screening
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving any other active investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving investigational agents
Participants may not be currently receiving any other experimental agents
Currently receiving any other investigational agents that are intended as treatments of GBM
Patients who are currently receiving any other investigational agents.
Currently receiving any investigational agents or registration on another therapy based trial
Currently receiving any other investigational agents
Participants who are currently receiving any other investigational agents
Receiving any other investigational agents currently, or within time limits specified above prior to study day 
Other investigational agents currently or within  days prior to study enrollment
Patients who are currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational agents that are intended as treatments of recurrent GBM
Patients currently receiving other investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational agents
Currently receiving any other investigational medication or therapy
Patients currently receiving any other investigational agents;
Currently receiving investigational agents in a clinical trial
Currently receiving investigational agents in a clinical trial
Participants who are currently receiving any other investigational agents or have received investigational agents within the past  months will be excluded
Patients may not be currently receiving any other investigational agents within  weeks of study registration
Patients must not currently be using other investigational agents
